Organic persistent room temperature phosphorescence enabled by carbazole impurity

The molecular design of metal-free organic phosphors is essential for realizing persistent room-temperature phosphorescence (pRTP) despite its spin-forbidden nature. A series of halobenzonitrile–carbazoles has been prepared following a one-pot nucleophilic substitution protocol involving commercially available and laboratory-synthesized carbazoles. We demonstrate how halo- and cyano-substituents affect the molecular geometry in the crystal lattice, resulting in tilt and/or twist of the carbazole with respect to the phenyl moiety. Compounds obtained from the commercially available carbazole result in efficient pRTP of organic phosphors with a high quantum yield of up to 22% and a long excited state lifetime of up to 0.22 s. Compounds obtained from the laboratory-synthesized carbazole exhibit thermally activated delayed fluorescence with an excited state lifetime in the millisecond range. In-depth photophysical studies reveal that luminescence originates from the mixed locally excited state (3LE, nπ*)/charge transfer state

Human Cataract Mutations in EPHA2 SAM Domain Alter Receptor Stability and Function

The cellular and molecular mechanisms underlying the pathogenesis of cataracts leading to visual impairment remain poorly understood. In recent studies, several mutations in the cytoplasmic sterile-α-motif (SAM) domain of human EPHA2 on chromosome 1p36 have been associated with hereditary cataracts in several families. Here, we have investigated how these SAM domain mutations affect EPHA2 activity. We showed that the SAM domain mutations dramatically destabilized the EPHA2 protein in a proteasome-dependent pathway, as evidenced by the increase of EPHA2 receptor levels in the presence of the proteasome inhibitor MG132. In addition, the expression of wild-type EPHA2 promoted the migration of the mouse lens epithelial αTN4-1 cells in the absence of ligand stimulation, whereas the mutants exhibited significantly reduced activity. In contrast, stimulation of EPHA2 with its ligand ephrin-A5 eradicates the enhancement of cell migration accompanied by Akt activation. Taken together, our studies suggest that the SAM domain of the EPHA2 protein plays critical roles in enhancing the stability of EPHA2 by modulating the proteasome-dependent process. Furthermore, activation of Akt switches EPHA2 from promoting to inhibiting cell migration upon ephrin-A5 binding. Our results provide the first report of multiple EPHA2 cataract mutations contributing to the destabilization of the receptor and causing the loss of cell migration activity

Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors

Background: The INTERVAL trial showed that, over a 2-year period, inter-donation intervals for whole blood donation can be safely reduced to meet blood shortages. We extended the INTERVAL trial for a further 2 years to evaluate the longer-term risks and benefits of varying inter-donation intervals, and to compare routine versus more intensive reminders to help donors keep appointments. Methods: The INTERVAL trial was a parallel group, pragmatic, randomised trial that recruited blood donors aged 18 years or older from 25 static donor centres of NHS Blood and Transplant across England, UK. Here we report on the prespecified analyses after 4 years of follow-up. Participants were whole blood donors who agreed to continue trial participation on their originally allocated inter-donation intervals (men: 12, 10, and 8 weeks; women: 16, 14, and 12 weeks). They were further block-randomised (1:1) to routine versus more intensive reminders using computer-generated random sequences. The prespecified primary outcome was units of blood collected per year analysed in the intention-to-treat population. Secondary outcomes related to safety were quality of life, self-reported symptoms potentially related to donation, haemoglobin and ferritin concentrations, and deferrals because of low haemoglobin and other factors. This trial is registered with ISRCTN, number ISRCTN24760606, and has completed. Findings: Between Oct 19, 2014, and May 3, 2016, 20 757 of the 38 035 invited blood donors (10 843 [58%] men, 9914 [51%] women) participated in the extension study. 10 378 (50%) were randomly assigned to routine reminders and 10 379 (50%) were randomly assigned to more intensive reminders. Median follow-up was 1·1 years (IQR 0·7–1·3). Compared with routine reminders, more intensive reminders increased blood collection by a mean of 0·11 units per year (95% CI 0·04–0·17; p=0·0003) in men and 0·06 units per year (0·01–0·11; p=0·0094) in women. During the extension study, each week shorter inter-donation interval increased blood collection by a mean of 0·23 units per year (0·21–0·25) in men and 0·14 units per year (0·12–0·15) in women (both p<0·0001). More frequent donation resulted in more deferrals for low haemoglobin (odds ratio per week shorter inter-donation interval 1·19 [95% CI 1·15–1·22] in men and 1·10 [1·06–1·14] in women), and lower mean haemoglobin (difference per week shorter inter-donation interval −0·84 g/L [95% CI −0·99 to −0·70] in men and −0·45 g/L [–0·59 to −0·31] in women) and ferritin concentrations (percentage difference per week shorter inter-donation interval −6·5% [95% CI −7·6 to −5·5] in men and −5·3% [–6·5 to −4·2] in women; all p<0·0001). No differences were observed in quality of life, serious adverse events, or self-reported symptoms (p>0.0001 for tests of linear trend by inter-donation intervals) other than a higher reported frequency of doctor-diagnosed low iron concentrations and prescription of iron supplements in men (p<0·0001). Interpretation: During a period of up to 4 years, shorter inter-donation intervals and more intensive reminders resulted in more blood being collected without a detectable effect on donors' mental and physical wellbeing. However, donors had decreased haemoglobin concentrations and more self-reported symptoms compared with the initial 2 years of the trial. Our findings suggest that blood collection services could safely use shorter donation intervals and more intensive reminders to meet shortages, for donors who maintain adequate haemoglobin concentrations and iron stores. Funding: NHS Blood and Transplant, UK National Institute for Health Research, UK Medical Research Council, and British Heart Foundation

Phosphorescent Carbene-Gold-Arylacetylide Materials as Emitters for Near UV-OLEDs.

Publication status: PublishedFunder: Lilian Schiff FoundationA series of carbene-gold-acetylide complexes [(BiCAAC)AuCC]n C6 H5-n (n = 1, Au1; n = 2, Au2; n = 3, Au3; BiCAAC = bicyclic(alkyl)(amino)carbene) have been synthesized in high yields. All complexes show excellent thermal stability up to 342°C. Compounds Au1-Au3 exhibit deep-blue to blue-green phosphorescence with good quantum yields up to 43% in all media. An increase of the (BiCAAC)Au moieties in gold complexes Au1-Au3 increases the extinction coefficients in the UV-vis spectra and stronger oscillator strength coefficients supported by theoretical calculations. The luminescence radiative rates decrease with an increase of the (BiCAAC)Au moieties. The time-dependent density functional theory (TD-DFT) study supports a charge-transfer nature of the phosphorescence due to the large (0.5-0.6 eV) energy gap between singlet excited (S1 ) and triplet excited (T1 ) states. Transient luminescence study reveals the presence of both non-structured UV prompt-fluorescence and vibronically resolved long-lived phosphorescence 428 nm. Organic light-emitting diodes (OLED) have been fabricated by physical vapour deposition with 2,8-bis(diphenylphosphoryl)dibenzo[b,d]furan (PPF) as a host material with complex Au1. The near-UV electroluminescence is observed at 405 nm with device efficiency of 1% while demonstrating OLED device lifetime LT50 up to 20 min at practical brightness of 10 nits, indicating a highly promising class of materials to develop stable UV-OLEDs. This article is protected by copyright. All rights reserved

Phosphorescent carbene-gold-arylacetylide materials as emitters for near UV-OLEDs

A series of carbene-gold-acetylide complexes [(BiCAAC)AuCC]nC6H5-n (n = 1, Au1; n=2, Au2; n=3, Au3; BiCAAC = bicyclic(alkyl)(amino)carbene) have been synthesized in high yields. All complexes show excellent thermal stability up to 342℃. Compounds Au1–Au3 exhibit deep-blue to blue-green phosphorescence with good quantum yields up to 43% in all media. An increase of the (BiCAAC)Au moieties in gold complexes Au1–Au3 increases the extinction coefficients in the UV-vis spectra and stronger oscillator strength coefficients supported by theoretical calculations. The luminescence radiative rates decrease with an increase of the (BiCAAC)Au moieties. The time-dependent density functional theory (TD-DFT) study supports a charge-transfer nature of the phosphorescence due to the large (0.5–0.6 eV) energy gap between singlet excited (S1) and triplet excited (T1) states. Transient luminescence study reveals the presence of both non-structured UV prompt-fluorescence and vibronically resolved long-lived phosphorescence 428 nm. Organic light-emitting diodes (OLED) have been fabricated by physical vapour deposition with 2,8-bis(diphenylphosphoryl)dibenzo[b,d]furan (PPF) as a host material with complex Au1. The near-UV electroluminescence is observed at 405 nm with device efficiency of 1% while demonstrating OLED device lifetime LT50 up to 20 min at practical brightness of 10 nits, indicating a highly promising class of materials to develop stable UV-OLEDs

Organic thermally activated delayed fluorescence material with strained benzoguanidine donor

Organic thermally activated delayed fluorescence (TADF) materials have been widely investigated due to their impressive electronic properties and applied potential for the third generation of organic light-emitting diodes (OLED). We present organic TADF material (4BGIPN) based on the strained benzoguanidine donor and compare it with the benchmark carbazole-based material (4CzIPN). Extended π-conjugation in 4BGIPN material results in yellow-green luminescence at 512 nm with a fast radiative rate of 5.5 × 10−5 s−1 and a photoluminescence quantum yield of 46% in methylcyclohexane solution. Such a nitrogen-rich 4BGIPN material has a significantly stabilized highest occupied molecular orbital (HOMO) at −6.4 eV while the lowest unoccupied molecular orbital (LUMO) at −4.0 eV, indicating potential suitability for application as the electron transport layer or TADF class III emitter in OLEDs